Literature DB >> 2859461

A common DNA polymorphism of the low-density lipoprotein (LDL) receptor gene and its use in diagnosis.

S E Humphries, A M Kessling, B Horsthemke, J A Donald, M Seed, N Jowett, M Holm, D J Galton, V Wynn, R Williamson.   

Abstract

A cloned gene probe coding for the low-density lipoprotein (LDL) receptor was used to detect a restriction fragment length polymorphism with the enzyme Pvu II. The frequency of the rare allele is approximately 0.2 both in normal controls and individuals with familial hypercholesterolaemia (FH). About 30% of individuals are heterozygous for the polymorphism, and are potentially informative for family studies and for early diagnosis of FH. This polymorphism was used to follow the inheritance of the LDL receptor gene in two families with FH. In these families, the polymorphism co-segregates with the disease unambiguously, and therefore can be used for early diagnosis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2859461     DOI: 10.1016/s0140-6736(85)91611-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  35 in total

1.  Effects of Ava II and Hinc II polymorphisms at the LDL receptor gene on serum lipid levels of Brazilian individuals with high risk for coronary heart disease.

Authors:  L A Salazar; M H Hirata; S D Giannini; N Forti; J Diament; J S Issa; R D Hirata
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

Review 2.  The use of recombinant DNA techniques for the diagnosis of familial hypercholesterolaemia.

Authors:  S Humphries; R Taylor; M Jeenah; M Seed
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

3.  TaqI polymorphism in the LDL receptor gene and a TaqI 1.5-kb band associated with familial hypercholesterolemia.

Authors:  K Yamakawa; T Okafuji; Y Iwamura; K Yuzawa; J Satoh; N Hattori; Y Yamanouchi; H Yanagi; K Kawai; S Tsuchiya
Journal:  Hum Genet       Date:  1988-09       Impact factor: 4.132

4.  Four DNA polymorphisms in the LDL receptor gene: their genetic relationship and use in the study of variation at the LDL receptor locus.

Authors:  R Taylor; M Jeenah; M Seed; S Humphries
Journal:  J Med Genet       Date:  1988-10       Impact factor: 6.318

5.  A study of familial hypercholesterolaemia in Iceland using RFLPs.

Authors:  R Taylor; J Bryant; V Gudnason; G Sigurdsson; S Humphries
Journal:  J Med Genet       Date:  1989-08       Impact factor: 6.318

6.  Multiple crm- mutations in familial hypercholesterolemia. Evidence for 13 alleles, including four deletions.

Authors:  H H Hobbs; E Leitersdorf; J L Goldstein; M S Brown; D W Russell
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

7.  Multiple mutations underlying familial hypercholesterolemia in the South African population.

Authors:  H E Henderson; M J Kotze; G M Berger
Journal:  Hum Genet       Date:  1989-08       Impact factor: 4.132

8.  Genetic determinants of serum lipid levels in Chinese subjects: a population-based study in Shanghai, China.

Authors:  Gabriella Andreotti; Idan Menashe; Jinbo Chen; Shih-Chen Chang; Asif Rashid; Yu-Tang Gao; Tian-Quan Han; Lori C Sakoda; Stephen Chanock; Philip S Rosenberg; Ann W Hsing
Journal:  Eur J Epidemiol       Date:  2009-11-04       Impact factor: 8.082

9.  Polymorphisms of genes in the lipid metabolism pathway and risk of biliary tract cancers and stones: a population-based case-control study in Shanghai, China.

Authors:  Gabriella Andreotti; Jinbo Chen; Yu-Tang Gao; Asif Rashid; Bingshu E Chen; Philip Rosenberg; Lori C Sakoda; Jie Deng; Ming-Chang Shen; Bing-Sheng Wang; Tian-Quan Han; Bai-He Zhang; Meredith Yeager; Robert Welch; Stephen Chanock; Joseph F Fraumeni; Ann W Hsing
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-02-22       Impact factor: 4.254

10.  Exclusion of the Friedreich ataxia gene from chromosome 19.

Authors:  S Chamberlain; C S Worrall; S South; J Shaw; M Farrall; R Williamson
Journal:  Hum Genet       Date:  1987-06       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.